Body Composition Analyzers Global Market Report 2025

The body composition analyzers market size has grown strongly in recent years. It will grow from $0.56 billion in 2024 to $0.61 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to rising health consciousness and awareness, a growing geriatric population, sedentary lifestyles combined with poor dietary habits, expansion of the fitness and sports industry, and increased investments in research and development.

The body composition analyzers market size is expected to see strong growth in the next few years. It will grow to $0.84 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the ongoing rise in global obesity rates, the expansion of corporate wellness initiatives, increased adoption by sports professionals, rising healthcare expenditures, and growing penetration into emerging markets. Key trends expected during this period include the integration of artificial intelligence (AI) and machine learning, the use of advanced sensors, the growth of wearable technology, increased digitalization, and the development of user-friendly software and AI-powered analysis tools.

The increasing prevalence of obesity is anticipated to drive the growth of the body composition analyzers market in the coming years. Obesity is a medical condition marked by excessive fat accumulation that significantly raises the risk of health issues such as cardiovascular diseases, diabetes, and musculoskeletal disorders. The rise in obesity rates is largely due to sedentary lifestyles, with more individuals spending extended periods sitting at desks, in front of screens, or during travel, resulting in reduced physical activity and energy expenditure that contributes to weight gain. Body composition analyzers play a crucial role in evaluating factors such as body fat percentage, muscle mass, and visceral fat, enabling healthcare professionals to effectively monitor and manage obesity-related health concerns. For example, in May 2024, a report from the UK’s Office for Health Improvement and Disparities indicated that during 2022 to 2023, around 64% of adults aged 18 and over were classified as overweight or obese, a slight rise from 63.8% the previous year. Thus, the growing prevalence of obesity is fueling the demand for body composition analyzers.

Leading companies in the body composition analyzer market are emphasizing the development of advanced technologies such as portable on-the-go testing solutions to enhance accessibility and convenience in both clinical and field settings. These portable solutions are compact, mobile diagnostic devices that facilitate accurate health assessments outside traditional healthcare environments, offering flexibility across various testing conditions. For example, in April 2022, InBody Co., Ltd., a South Korea-based medical device manufacturer, introduced the BWA 2 Body Water Analyzer. This professional-grade device is designed for portability and enables body composition and water analyses in multiple positions - supine, seated, or standing - making it particularly beneficial for individuals with limited mobility or amputations. An upgrade from the InBody S10, the BWA 2 performs 40 impedance measurements using eight frequencies and provides up to seven types of result sheets tailored to clinical, research, pediatric, and fitness needs. Its mobile-friendly design ensures precise results and supports versatile on-site testing across a range of healthcare and wellness environments.

In May 2025, Function Health, a US-based health empowerment platform provider, acquired Ezra for an undisclosed sum. This acquisition is intended to reduce scan times and costs, enhance early detection of health conditions, and establish a new benchmark in healthcare by combining advanced lab testing with imaging technology to improve accessibility to health screenings. Ezra is a US-based company specializing in body composition analyzers and screening equipment.

Major players in the body composition analyzers market are GE HealthCare Technologies Inc., Omron Healthcare Co Ltd., Hologic Inc., InBody Co Ltd., Seca GmbH & Co KG, Withings SA, Jawon Medical Co Ltd., Tanita Corporation, Ezra Scan Inc., RJL Systems Inc., Motustech Co Ltd., Evolt 360 Pty Ltd, COSMED S.R.L., Selvas Healthcare Inc., ACCUNIQ Co Ltd., Charder Electronic Co Ltd., OsteoSys Corp., Bodystat Ltd., Medzone Healthcare, and Maltron International Ltd.

North America was the largest region in the body composition analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in body composition analyzers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the body composition analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Body composition analyzers are instruments designed to assess the distribution of fat, muscle, bone, and water in the human body. They offer comprehensive insights into an individual's overall health and fitness, going beyond basic measurements like body weight. These devices provide accurate, non-invasive evaluations and are capable of delivering results quickly.

The primary types of body composition analyzers include bioimpedance analyzers, skinfold calipers, hydrostatic weighing equipment, air displacement plethysmography, dual-energy X-ray absorptiometry (DEXA), and others. A bioimpedance analyzer, for example, estimates body composition by detecting the resistance of body tissues to a low, safe electrical current. These devices support different compartment models - such as the two-compartment, three-compartment, and multi-compartment models - and are utilized by various end users, including hospitals, fitness clubs and wellness centers, academic institutions, research centers, and more.

The body composition analyzers market research report is one of a series of new reports that provides body composition analyzers market statistics, including body composition analyzers industry global market size, regional shares, competitors with a body composition analyzers market share, body composition analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the body composition analyzers industry. This body composition analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The body composition analyzers market consists of sales of hydrostatic weighing systems, skinfold calipers, dual-energy X-ray absorptiometry scanners, and bioelectrical impedance analysis devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.